Stay updated with breaking news from Caplin Point. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dipan Mehta advises caution and light trading ahead of the upcoming election dates. He emphasizes the importance of being in cash and watching the election results closely for investment decisions.
Asit C Mehta recommended accumulate rating on Caplin Point Laboratories with a target price of Rs 1675 in its research report dated April 25 2024.
It says Ebitda margins may reach 24.9%, boosted by product mix and cost control; long-term growth outlook positive, focused on complex products, domestic demand, and R&D investments
The Nifty 50 settled 0.08% lower at 22,434, while Sensex shed 0.04% to 73,877. Nifty 50 formed a small positive candle on the daily chart with a gap down opening and with an upper shadow. Technically this pattern indicates broader range movement in the market near all-time highs, said Nagaraj Shetti, senior technical research analyst at HDFC Securities. The MACD showed bearish signs on the counters of P&G, and Caplin Point among others.
Sectorally, buying was seen in realty, IT, metal, auto, and healthcare stocks, while selling pressure was seen in the banking space. Stocks that were in focus include names like AstraZeneca Pharma, which rose more than 13% to hit a fresh high, Caplin Point, which gained more than 8%, and JB Chemicals, which closed with gains of over 9% to hit a fresh record high.